Myriad Genetics: (NASD: MYGN)

$32.93

-0.20 (-0.60%)

Volume 1,685,179

May 17 04:00 PM ET

Zacks Rank: 2-Buy

 
#2
 
 
 

Earnings Announcements

Get Earnings Announcements for:

Earnings Announcements for MYGN

Date Period Ending Estimate Reported Surprise Time
05/07/2013 03/2013 $0.39 $0.46
+0.07 (17.95%)
After Close
02/05/2013 12/2012 $0.38 $0.42
+0.04 (10.53%)
After Close
11/05/2012 09/2012 $0.32 $0.36
+0.04 (12.50%)
After Close
08/14/2012 06/2012 $0.34 $0.34
0.00 (0.00%)
After Close
05/01/2012 03/2012 $0.32 $0.34
+0.02 (6.25%)
After Close
01/31/2012 12/2011 $0.31 $0.33
+0.02 (6.45%)
After Close
11/01/2011 09/2011 $0.27 $0.29
+0.02 (7.41%)
After Close
08/09/2011 06/2011 $0.28 $0.30
+0.02 (7.14%)
After Close
05/03/2011 03/2011 $0.25 $0.31
+0.06 (24.00%)
After Close
01/27/2011 12/2010 $0.26 $0.26
0.00 (0.00%)
After Close
11/02/2010 09/2010 $0.23 -- -- After Close
08/10/2010 06/2010 $0.33 -- -- After Close
05/04/2010 03/2010 $0.38 -- -- After Close
02/02/2010 12/2009 $0.34 -- -- After Close
11/03/2009 09/2009 $0.32 -- -- After Close
08/25/2009 06/2009 $0.23 -- -- After Close
05/04/2009 03/2009 $0.23 -- -- After Close

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.